DAB.bio closed a funding round (amount undisclosed) in Oct 2025. The company is based in Delft, Netherlands. Investors in the round: Capricorn Partners, Navus Ventures. Data as of 21 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
